Home > Healthcare > U.S. Bioreactors Market > Table of Contents

U.S. Bioreactors Market – By Product Type (Single-use, Reusable), Cell (Mammalian, Bacterial, Yeast), Molecule (Vaccines, mAbs), Material (Stainless Steel, Glass, Single-use), Size (<500L, 501-5,000L, >5,000L), Usage, End-use – Forecast 2024 – 2032

  • Report ID: GMI10829
  • Published Date: Aug 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Growing pharmaceutical and biotechnology industry

3.2.1.2    Technological advancements in bioreactors

3.2.1.3    Growing focus on orphan drug development

3.2.1.4    Rising demand for personalized medicines

3.2.2    Industry pitfalls & challenges

3.2.2.1    Low capacity of single-use bioreactors

3.2.2.2    Concerns regarding extractables and/or leachables

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technological landscape

3.6    Porter’s analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Competitive analysis of major market players

4.4    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn, Units)

5.1    Key trends

5.2    Single-use

5.2.1    Size

5.2.1.1    Less than 500 L

5.2.1.2    501-5,000 L

5.2.1.3    More than 5,000 L

5.3    Reusable

5.3.1    Size

5.3.1.1    Less than 500 L

5.3.1.2    501-5,000 L

5.3.1.3    More than 5,000 L

5.3.2    Material

5.3.2.1    Stainless steel

5.3.2.2    Glass

Chapter 6   Market Estimates and Forecast, By Cell, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Mammalian cells

6.3    Bacterial cells

6.4    Yeast cells

6.5    Other cells

Chapter 7   Market Estimates and Forecast, By Molecule, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Monoclonal antibodies

7.3    Vaccines

7.4    Recombinant proteins

7.5    Stem cells

7.6    Gene therapy

7.7    Other molecules

Chapter 8   Market Estimates and Forecast, By Usage, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Developmental, pre-clinical & clinical

8.3    Commercial production

Chapter 9   Market Estimates and Forecast, By Material, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    Stainless steel

9.2.1    Size

9.2.1.1    Less than 500 L

9.2.1.2    501-5,000 L

9.2.1.3    More than 5,000 L

9.3    Glass

9.4    Single-use

Chapter 10   Market Estimates and Forecast, By Size, 2021 – 2032 ($ Mn)

10.1    Less than 500 L

10.1.1   Single-use

10.1.2   Reusable

10.1.2.1    Stainless Steel

10.1.2.2    Glass

10.2    501-5,000 L

10.2.1   Single-use

10.2.2   Reusable

10.3    More than 5,000 L

10.3.1   Stainless steel

10.3.2   Single-Use

Chapter 11   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

11.1    Key trends

11.2    R&D organizations

11.3    Biopharma manufacturers

11.4    Contract manufacturing organizations (CMOs)

Chapter 12   Company Profiles

12.1    Altrad Group

12.2    BaiLun Biotechnology Co., Ltd

12.3    Danaher Corporation

12.4    Donaldson Company, Inc

12.5    Eppendorf Group

12.6    Esco Micro Pte. Ltd.

12.7    GEA Group Aktiengesellschaft

12.8    Getinge AB

12.9    Merck KGaA

12.10    PBS Biotech, Inc.

12.11    Sartorius AG

12.12    Thermo Fisher Scientific Inc.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 148
  • Countries covered: 1
  • Pages: 100
 Download Free Sample